(Q43251154)

17 November 2017

title

Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study (English)

1 reference

chronic obstructive pulmonary disease

17 November 2017

main subject

1 reference

1 reference

2

Antonio Anzueto

1 reference

17 November 2017

1

Marc Miravitlles

1 reference

17 November 2017

Santiago Ewig

3

1 reference

17 November 2017

Delfino Legnani

series ordinal

4

1 reference

17 November 2017

Kathrin Stauch

series ordinal

5

1 reference

17 November 2017

publication date

30 October 2009

1 reference

Therapeutic advances in respiratory disease

17 November 2017

published in

1 reference

17 November 2017

volume

3

1 reference

17 November 2017

issue

6

1 reference

17 November 2017

page(s)

267-277

1 reference

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Why we need observational studies to evaluate the effectiveness of health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Epidemiology and costs of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

21 January 2018

Primary care spirometry.

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Chronic obstructive pulmonary disease: the disease and its burden to society

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Daily-practice treatment of acute exacerbations of chronic bronchitis with moxifloxacin in a large cohort in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Do we need new antibiotics for treating exacerbations of COPD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Patient's perception of exacerbations of COPD--the PERCEIVE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Geographic differences in clinical characteristics and management of COPD: the EPOCA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Guidelines for the management of adult lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Determining Factors in the Prescription of Moxifloxacin in Exacerbations of Chronic Bronchitis in??the Primary-Care Setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Use of spirometry and patterns of prescribing in COPD in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Antimicrobial Treatment of Exacerbation in Chronic Obstructive Pulmonary Disease: 2007 Consensus Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

Speed of Recovery from Acute Exacerbations of Chronic Obstructive Pulmonary Disease after Treatment with Antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465809352791

21 January 2018

Identifiers

DOI

10.1177/1753465809352791

1 reference

17 November 2017

1 reference